Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
PVLA
ZYME
Add up to 3 more stocks
PVLA
Palvella Therapeutics, Inc.
-3.15%
$128.00-4.16Delayed quote: Oct 6, 2026, 4:00 PM EDT
Market Cap
$1.84B
52W Range
$65.93 - $161.38
ZYME
Zymeworks Inc.
-2.14%
$25.65-0.56Delayed quote: Oct 6, 2026, 4:00 PM EDT
Market Cap
$1.89B
52W Range
$16.00 - $31.34
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | N/A |
| Forward P/E | N/A | 24.73 |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 8.47 | 23.48 |
| P/S Ratio | N/A | 50.83 |
| P/FCF Ratio | N/A | N/A |
| EV/EBITDA | N/A | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 0.0% | 100.0% |
| Operating Margin | 0.0% | -87.3% |
| Net Margin | 0.0% | -404.0% |
| ROE | -28.4% | -186.6% |
| ROA | -24.3% | -37.8% |
| ROIC | -23.9% | -44.1% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 21.18 | 6.32 |
| Quick Ratio | 21.18 | 6.32 |
| Debt/Equity | 0.00 | 3.34 |
| Interest Coverage | -6.63 | N/A |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.